What You Should Know:– Lucem Health™ today announced the availability of its new early AI-driven disease detection solutions, Lucem Health Reveal that leverages existing EHR data to identify patients who may be at a…
Continue Reading
The following is a guest article by Josh Miller, Co-Founder & CEO at Gradient Health.
As a global society, we have never spent more on healthcare. We have never been more informed. We’ve never been…
What You Should Know:– PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia’s software platform (Concentriq® Dx) to further enhance the delivery of…
Continue Reading
What You Should Know:– PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia’s software platform (Concentriq® Dx) to further enhance the delivery of…
Continue Reading
We like to regularly feature a healthcare IT job that might be of interest to readers. Today, we’re featuring the Healthcare Data Analyst position that was recently posted on Healthcare IT Central. This position was…
Continue Reading
Sponsored by Consensus Cloud Solutions
March 01, 2023 – Health data exchange is essential to meaningful patient care. Providers must be able to leverage accurate and timely health information at the point of care to…
As we build technology to solve problems in healthcare- there is one really important asset that we can often overlook or maybe not give much time of day. But it is extremely essential because…
Continue Reading
Anne Kim, Co-Founder and CEO of Secure AI Labs (SAIL)Clinical research is only as good and thorough as the data that’s available — and we need to do a better job of making that…
Continue Reading
February 28, 2023 Headlines No Comments Local Leaders Announce Plan to Strengthen Health Services in Imperial County
UC San Diego Health considers sharing its EHR with El Centro Regional Medical Center as part…
Friedrich’s ataxia, an ultra-rare disease that causes progressively worsening muscle function that ultimately leads to death, now has its first FDA-approved therapy. The regulator has given the green light to a Reata Pharmaceuticals drug…
Continue Reading
